midterm 2 Flashcards

1
Q

Drug solubility In pharmaceutical solutions both the ___ and the ___ are legally required to be present in solution over the shelf-life of the formulated product.

A

THERAPEUTIC AGENTS
EXCIPIENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The dissolution of a therapeutic agent in water involves several key molecular steps:

A

REMOVAL OF A MOLECULE OF THE DRUG FROM THE SOLID STATE

FORMATION OF A CAVITY WITHIN THE SOLVENT

ACCOMMODATION OF THE DRUG MOLECULE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

breakage of solute-solute and solvent-solvent bonds

A

ENDOTHERMIC PROCESSES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

It occurs whenever the Gibb’s free energy of the process is NEGATIVE and involves a balance between the enthalpy of dissolution and the associated entropy at the temperature of dissolution (T).

A

DISSOLUTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

It is a thermodynamic potential that measures the maximum amount of reversible work that can be performed by a thermodynamic system at constant temperature and pressure.

A

GIBB’S FREE ENERGY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Refers to the thermodynamic capacity of API.

A

ENTHALPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Refers to the m easurement of the degree of randomness or spontaneity of API.

A

ENTROPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Factors affecting the solubility of therapeutic agents:

A

• molecular weight
• Volume
• radius of gyration Density
• number of rotatable bonds
• hydrogen bond donors and
• hydrogen bond acceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

as the melting point of the therapeutic agent is increased, the solubility would be expected to decrease

A

INVERSELY RELATED TO THEIR MELTING POINTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

It is directly affected by both the type of chemical substituent groups and the substituent position.

A

THERAPEUTIC AGENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

thesolubilitiesoftherapeuticagentsthatareeitheracidsorbases (representing the vast majority of drug substances) are __

A

pH-DEPENDENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

are physiologically inert compounds.

A

EXCIPIENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

It facilitates the administration of the dosage form, e.g. pourability, palatability

A

EXCIPIENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

• protect the formulation from issues regarding physical and chemical stability
• enhance the solubility of the therapeutic agent.

A

EXCIPIENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

It is commonly used due to the low cost and low toxicity of this ingredient.

A

PURIFIED WATER, USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

■ It is prepared by distillation, ion exchange methods or by reverse osmosis.
■ The solid residue (obtained after evaporation) is less than 1 mg per 100 ml of evaporated sample.

A

PURIFIED WATER, USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

■ It must not be used for the preparation of parenteral formulations.

A

PURIFIED WATER, USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

It is an odorless, sweet liquid that is miscible with water and whose co-solvency properties are due to the presence of three hydroxyl groups (termed a triol).

A

GLYCEROL (GLYCERIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

It has similar co-solvency properties to ethanol.

A

GLYCEROL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

It contains between 94.9 and 96.0% v/v ethyl alcohol (ethanol) and is commonly used as a co-solvent, both as a single co-solvent and with other co-solvents, e.g. glycerol

A

ALCOHOL USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

It is an odourless, colourless, viscous liquid diol that contains two hydroxyl groups. It is used in pharmaceutical preparations as a co-solvent, generally as a replacement for glycerin.

A

PROPYLENE GLYCOL USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

It is a polymer composed of repeating units of the monomer ethylene oxide, Lower-molecular-weight grades (PEG 200, PEG 400) are preferred as co-solvents in pharmaceutical solutions

A

POLY(ETHYLENE GLYCOL) PEG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

These are chemicals that possess both hydrophilic (water-liking) and hydrophobic (water-disliking) regions.

A

SURFACE-ACTIVE AGENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

It would prevent drug absorption across biological membranes

A

DRUG-POLYMER COMPLEX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
These are employed within pharmaceutical solutions to control the pH of the formulated product and, in so doing, optimise the physicochemical performance of the product.
BUFFERS
26
Examples of buffer salts used in pharmaceutical solutions
- ACETATES (ACETIC ACID AND SODIUM ACETATE) - CITRATES (CITRIC ACID AND SODIUM CITRATE) - PHOSPHATES (SODIUM PHOSPHATE AND DISODIUM PHOSPHATE)
27
are employed in liquid formulations designed for oral administration specifically to increase the palatability of the therapeutic agent.
SWEETENING AGENTS
28
The main sweetening agents employed in oral preparations are:
SUCROSE LIQUID GLUCOSE GLYCEROL SORBITOL SACCHARIN SODIUM ASPARTAME
29
It is used either as the sole sweetening agent or in combination with sugars or sorbitol to reduce the sugar concentration in the formulation.
SACCHARIN SODIUM
30
The administration of oral solutions to patients is usually performed using a
SYRINGE SMALL-METERED CUP TRADITIONAL 5-ML SPOON
31
The viscosity of pharmaceutical solutions may be easily increased (and controlled) by the:
ADDITION OF NON-IONIC OR IONIC HYDROPHILIC POLYMERS
32
cellulose derivatives
NON-IONIC (NEUTRAL) POLYMERS
33
examples of non ionic (neutral) polymers
METHYLCELLULOSE HYDROXYETHYLCELLULOSE HYDROXYPROPYLCELLULOSE
34
polyvinylpyrrolidone
HYDROXYPROPYLCELLULOSE
35
sodium carboxymethylcellulose (anionic) – sodium alginate (anionic)
IONIC POLYMERS
36
These are molecules that are redox systems that exhibit higher oxidative potential than the therapeutic agent or, alternatively, are compounds that inhibit free radical-induced drug decomposition.
ANTIOXIDANTS
37
Examples of antioxidants that may be used in oil-based solutions include:
BUTYLATED HYDROXYTOLUENE (BHT) BUTYLATED HYDROXYANISOLE (BHA) PROPYL GALLATE
38
These are included in pharmaceutical solutions to control the microbial bioburden of the formulation.
PRESERVATIVES
39
These are employed whenever the unpalatable taste of a therapeutic agent is apparent, even in the presence of the sweetening agents.
FLAVORS
40
These are generally natural or synthetic water soluble, photo-stable ingredients that are selected according to the flavour of the preparation.
COLOURS
41
These are viscous preparations that contain the therapeutic agent dissolved in a vehicle composed of a high percentage of sucrose and, if required, other sweetening agents.
LINCTUSES
42
It occurs whenever the Gibb’s free energy of the process is negative and involves a balance between the enthalpy of dissolution and the associated entropy at the temperature of dissolution (T).
DISSOLUTION
43
Oral Liquid Dosage Forms
SYRUP ORAL SOLUTION ORAL DROP ORAL EMULSION MIXTURE LINCTUSES ELIXIR
44
The aqueous solubility of the therapeutic agent is _____ of the formulation. Under these circumstances the therapeutic agent may be ______ and formulated as an oral solution.
- high at the selected pH - readily incorporated into the vehicle
45
The aqueous solubility of the therapeutic agent is _____ of the formulation, i.e. the aqueous solubility is less than the requested concentration of therapeutic agent.
- moderate at the selected pH
46
Example of alternative-dosage form
SUSPENSION
47
commonly employed co-solvents
GLYCEROL PROPYLENE GLYCOL ETHANOL POLY(ETHYLENE GLYCOL)
48
most commonly used vehicle for oral administration
PURIFIED WATER USP
49
Control of the pH in the formulation is achieved using a buffer that does not adversely affect the solubility of the therapeutic agent.
50
solubility of acidic compounds increases as the pH of the solution is increased (above the pKa) and the solubility of basic compounds increases as the pH is lowered below the pKa.
51
these are preferred due to the lack of toxicity of water as the vehicle
AQUEOUS SOLUTIONS
52
The solid residue (obtained after evaporation) of purified water usp is
less then 1mg per 100 ml of evaporated sample
53
main co-solvents used in the formulation of oral solutions
GLYCEROL (GLYCERIN) ALCOHOL USP (CH3CH2OH) PROPYLENE GLYCOL USP POLY(ETHYLENE GLYCOL) PEG SURFACE-ACTIVE AGENTS DRUG-POLYMER COMPLEX
54
increasing the viscosity of some formulations may increase the palatability.
VISCOSITY-ENHANCING AGENTS
55
It may be easily increased (and controlled) by the addition of non-ionic or ionic hydrophilic polymers.
VISCOSITY OF PHARMACEUTICAL SOLUTIONS
56
it possess a broad spectrum of antimicrobial activity encompassing Gram-positive and Gram-negative bacteria and fungi
PRESERVATIVES
57
be chemically and physically stable over the shelf-life of the product have low toxicity.
PRESERVATIVES
58
preservatives available for use in pharmaceutical solutions for oral use
BENZOIC ACID AND SALTS (0.1 to 0.3%) SORBIC ACID AND SALTS (0.05 to 0.2%) ALKYL ESTERS AND PARAHYDROXYBENZOIC ACID (0.001 to 0.2%)
59
liquid products to be used as injections, eye drops or vaccines sterility, these tests are necessary as additional tests.
APYROGENICITY TESTING PARTICULATE MATTER TESTING
60
It refers to the property of a substance or a product that is free from pyrogens
Apyrogenicity
61
are substance that can induce Fever when introduced into the body. They are often bacterial endotoxins, which are components of the cell wall of Gram-negative bacteria
Pyrogens